MYCELX Technologies (LON:MYX) Rating Reiterated by Canaccord Genuity Group

MYCELX Technologies (LON:MYXGet Free Report)‘s stock had its “speculative buy” rating reaffirmed by stock analysts at Canaccord Genuity Group in a research report issued on Tuesday, LSE.Co.UK reports. They currently have a GBX 95 ($1.27) price objective on the stock. Canaccord Genuity Group’s price target indicates a potential upside of 144.85% from the company’s current price.

MYCELX Technologies Trading Down 1.8 %

Shares of LON MYX traded down GBX 0.70 ($0.01) during trading on Tuesday, reaching GBX 38.80 ($0.52). The company had a trading volume of 136,135 shares, compared to its average volume of 26,116. The stock has a market cap of £9.45 million, a P/E ratio of -323.33 and a beta of 1.00. The company’s fifty day moving average price is GBX 52.74 and its 200-day moving average price is GBX 54.76. The company has a quick ratio of 2.97, a current ratio of 2.36 and a debt-to-equity ratio of 12.42. MYCELX Technologies has a 12 month low of GBX 36.25 ($0.49) and a 12 month high of GBX 71.64 ($0.96).

Insider Buying and Selling at MYCELX Technologies

In other news, insider André Schnabl bought 48,836 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was acquired at an average price of GBX 51 ($0.68) per share, with a total value of £24,906.36 ($33,350.78). Insiders own 19.26% of the company’s stock.

MYCELX Technologies Company Profile

(Get Free Report)

MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the oil and gas, power, marine, and heavy manufacturing sectors in the Middle East, the United States, Nigeria, Australia and internationally. The company offers oil removal solutions for upstream produced water to oil companies; and hydrocarbons removal services from downstream process wastewater that are used in petrochemical facilities and refineries.

Featured Stories

Receive News & Ratings for MYCELX Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYCELX Technologies and related companies with MarketBeat.com's FREE daily email newsletter.